Cerebral Cavernous Malformation
Neurology·MeSH: Hemangioma, Cavernous, Central Nervous System
Prevalence
30.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Cerebral Cavernous Malformation?
BioSniper tracks 2 drugs in development for Cerebral Cavernous Malformation across 2 companies.
How many clinical trials target Cerebral Cavernous Malformation?
There are 1 clinical trial targeting Cerebral Cavernous Malformation tracked by BioSniper.
What is the prevalence of Cerebral Cavernous Malformation?
The estimated prevalence of Cerebral Cavernous Malformation is approximately 30.0 per 100,000 population.
Deep-dive into Cerebral Cavernous Malformation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis